Table III.
1–2 grade adverse events | 3–4 grade adverse events | |||
---|---|---|---|---|
Hematological toxicity | Number, n | Percentage (n=205) | Number, n | Percentage (n=205) |
Neutropenia | 1 | 0.5 | 5 | 2.5 |
Thrombocytopenia | 4 | 2.0 | 1 | 0.5 |
Anemia | 12 | 6.0 | – | – |
VTD, bortezomib, thalidomide, dexamethasone.